TD-4208
0130
Phase 3 small_molecule completed
Quick answer
TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) is a Phase 3 program (small_molecule) at Theravance Biopharma with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed